Home › Cholesterol
Cholesterol clinical trials recruiting in the U.S.
22 studies for Cholesterol are recruiting participants at sites across the United States.
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
Cities with the most studies
- Washington, DC6 studies
- Hialeah, FL5 studies
- Clearwater, FL4 studies
- Richmond, VA4 studies
- Jacksonville, FL4 studies
- Deltona, FL4 studies
- Durham, NC4 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- Chicago, IL3 studies
- Houston, TX3 studies
- Alexandria, VA3 studies
- Wichita, KS3 studies
- New York City, NY3 studies
- St. Louis, MO3 studies
- Salt Lake City, UT3 studies
By state
- Alabama5 studies
- Arizona3 studies
- California6 studies
- Florida7 studies
- Georgia4 studies
- Illinois4 studies
- Indiana3 studies
- Kansas3 studies
- Kentucky3 studies
- Louisiana4 studies
- Maryland4 studies
- Missouri4 studies
- New York5 studies
- North Carolina7 studies
- Ohio3 studies
- Oklahoma3 studies
- Oregon3 studies
- Pennsylvania4 studies
- South Carolina4 studies
- Tennessee3 studies
- Texas6 studies
- Utah3 studies
- Virginia5 studies
- Washington3 studies
Recently updated studies
Causes and Natural History of Dyslipidemias
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Sep 29, 2026 · NCT00353782Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
Recruiting
All ages · All sexes · Updated Sep 29, 2026 · NCT06743659Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07799961A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Jul 24, 2026 · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 22, 2026 · NCT07477704Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jul 17, 2026 · NCT06451770Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Recruiting
Ages 18 to 60 · All sexes · Updated Jul 16, 2026 · NCT06988462Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated May 15, 2026 · NCT06597019Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
RecruitingHealthy volunteers welcome
Ages 18 to 74 · All sexes · Updated Apr 17, 2026 · NCT07514663Pharmacogenomic Informed Statin Prescribing
Recruiting
Ages 40 to 75 · All sexes · Updated Apr 13, 2026 · NCT06568601Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
RecruitingHealthy volunteers welcome
Ages 18 to 39 · All sexes · Updated Mar 23, 2026 · NCT06894004Multicomponent Intervention Study- Blood Donors With High Cholesterol
Recruiting
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT05693701Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Feb 27, 2026 · NCT06488105Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Recruiting
Ages 18 and older · All sexes · Updated Jan 29, 2026 · NCT06374277FELLAShip to Better Health
Recruiting
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT07220213HoFH, the International Clinical Collaborators Registry
RecruitingObservational study
All ages · All sexes · Updated Dec 18, 2025 · NCT04815005Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 69 · All sexes · Updated Oct 1, 2025 · NCT06747000Alirocumab in Patients on a Stable Dialysis Regimen
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Feb 12, 2020 · NCT03480568From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.